X4 Pharmaceuticals, Inc
XFOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501697
In the last 90 days, X4 Pharmaceuticals, Inc insiders filed 0 open-market purchases and 3 sales; 89 institutions reported holding it in 13F filings for Q2 2026, worth $463.0M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding X4 Pharmaceuticals, Inc changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 51 | 1 | 59 | +9 |
| Shares | 16.1M | 55.0K | 39.1M | +23.1M (+144.5%) |
| Value | $15.5M | $53.0K | $66.9M | +$51.4M (+332.2%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (14)
Institutions that held X4 Pharmaceuticals, Inc at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| NEA Management Company, LLC | 6,523,157 | $11.2M | 0.56% |
| Parkman Healthcare Partners LLC | 950,000 | $1.63M | 0.46% |
| Susquehanna International Group, LLP | 150,597 | $258.0K | 0.00% |
| PEAK6 Investments LLC | 60,200 | $103.0K | 0.00% |
| Goldman Sachs Group Inc | 55,380 | $95.0K | 0.00% |
| BIT Capital GmbH | 45,000 | $77.0K | 0.01% |
| Charles Schwab Investment Management Inc | 42,386 | $73.0K | 0.00% |
| Group One Trading, L.P. | 32,876 | $56.0K | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 23,065 | $39.0K | 0.00% |
| LexAurum Advisors, LLC | 16,000 | $27.0K | 0.01% |
| Simplex Trading, LLC | 11,237 | $19.0K | 0.00% |
| FMR LLC | 10,000 | $17.0K | 0.00% |
| Royal Bank of Canada | 101 | $0 | 0.00% |
| CWM, LLC | 2 | $0 | 0.00% |
Sold out (5)
Institutions that held X4 Pharmaceuticals, Inc at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Citadel Advisors LLC | 45,254 | $44.0K |
| Virtu Financial LLC | 20,385 | $20.0K |
| Tower Research Capital LLC (TRC) | 5,639 | $5.00K |
| Barclays PLC | 100 | $0 |
| Cubist Systematic Strategies, LLC | 384 | $0 |
Not filed for Q3 2022 yet (1)
Institutions that held X4 Pharmaceuticals, Inc at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Minot Wealth Management LLC | 55,000 | $53.0K |